18:11 , Jul 27, 2018 |  BC Week In Review  |  Financial News

With Ex-Receptos execs at helm, Gossamer raises another large round

Gossamer Bio Inc. (San Diego, Calif.) raised $230 million on July 23 in an untranched series B round led by new investor Hillhouse Capital, bringing the biotech's total funding to $330 million since its January...
20:56 , Jul 26, 2018 |  BioCentury  |  Finance

Gossamer’s war chest

Gossamer Bio Inc. has built a huge war chest from investors lured by the prospect of near-term milestones, a plan for rapid pipeline growth and a winning management team from Receptos Inc. With Monday’s $230...
20:21 , Jul 23, 2018 |  BC Extra  |  Financial News

Ex-Receptos team snags another big round at Gossamer

Gossamer Bio Inc. (San Diego, Calif.) raised $230 million in an untranched series B round led by new investor Hillhouse Capital, bringing the biotech's total funding to $330 million since its January launch. Also participating...
18:29 , Jun 29, 2018 |  BC Week In Review  |  Financial News

Flagship-backed Kaleido raises $101M series C round

Microbiome company Kaleido Biosciences Inc. (Bedford, Mass.) raised $101 million in a series C round. Founding investor Flagship Pioneering participated, as did several new investors including an affiliate of Abu Dhabi Investment Authority, Fidelity, Invus...
21:51 , Jun 25, 2018 |  BC Extra  |  Financial News

Flagship-backed Kaleido raises $101M series C round

Microbiome company Kaleido Biosciences Inc. (Bedford, Mass.) raised $101 million in a series C round. Founding investor Flagship Pioneering participated, as did several new investors including an affiliate of Abu Dhabi Investment Authority, Fidelity, Invus...
20:13 , Feb 9, 2018 |  BC Week In Review  |  Financial News

mRNA company Moderna raises $500M series G

Moderna Therapeutics Inc. (Cambridge, Mass.) raised $500 million in an untranched series G round on Feb. 1. New investors included an Abu Dhabi Investment Authority subsidiary, BB Biotech AG (SIX:BION; Xetra:BBZA), Julius Baer, EDBI and...
22:07 , Feb 2, 2018 |  BioCentury  |  Finance

Private ambition

BB Biotech AG (SIX:BION; Xetra:BBZA) made a rare private investment in Moderna Therapeutics Inc.’s $500 million series G round and wants to see clinical proof-of-concept data from at least one rare liver disease asset before...
21:29 , Feb 1, 2018 |  BC Extra  |  Financial News

mRNA play Moderna raises $500M series G

Moderna Therapeutics Inc. (Cambridge, Mass.) raised $500 million in an untranched series G round. New investors included an Abu Dhabi Investment Authority subsidiary, BB Biotech AG (SIX:BION; Xetra:BBZA), Julius Baer, EDBI and Sequoia Capital China....